| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/20/2001 | US6319714 Generating genetically engineered nucleotide sequences; mix primers, polymerase, and separate nucleotide sequences, incubate, add ligase, recover genetically engineered products |
| 11/20/2001 | US6319713 Methods and compositions for polypeptide engineering |
| 11/20/2001 | US6319710 Isolated nucleic acid molecule operatively linked to a regulatory sequence |
| 11/20/2001 | US6319709 Tumor cells with increased immunogenicity and uses therefor |
| 11/20/2001 | US6319693 Cloning of chicken anemia virus DNA |
| 11/20/2001 | US6319691 Fusion proteins comprising IFN-alpha2b and TM-alpha1 |
| 11/20/2001 | US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1) |
| 11/20/2001 | US6319687 Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene |
| 11/20/2001 | US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools |
| 11/20/2001 | US6319685 Polypeptide for generation of amidated agricultral and medical products |
| 11/20/2001 | US6319677 Monitoring seed development; evaluate migration of globulins in seed extracts, migration of globulins indicates seed development activity |
| 11/20/2001 | US6319675 Methods for detecting and/or identifying agents which bind and/or modulate function of “bonzo” chemokine receptor |
| 11/20/2001 | US6319669 Nucleotide sequences coding luminescent polypeptides; for use as genetic tools in monitoring intracelular positions of preferential polypeptides and preferential gene expression |
| 11/20/2001 | US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 11/20/2001 | US6319666 Treating humans for viral infections; incubate human with antigen, monitor immunological response, screen for presence of viral proteins |
| 11/20/2001 | US6319522 Growth-promoting agent |
| 11/20/2001 | US6319505 Administering to patient suffering from tardive dyskinesia effective amount of botulinum toxin selected from types c, e, and g, thereby alleviating symptoms |
| 11/20/2001 | US6319504 Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
| 11/20/2001 | US6319503 Fusion protein comprising ubiquitin fused to single epitope-containing segment comprising two or more identical epitopes, wherein segment is not cleaved from protein by exposure to ubiquitin-specific proteases; immunogens |
| 11/20/2001 | US6319502 Immunogenic polypeptide; treating malaria |
| 11/20/2001 | US6319501 Vaccine comprising hepatitis b virus surface antigen having sequence (ctkpsdgnc) within residues s(139-147) and at least one non-permitted variant of said surface antigen |
| 11/20/2001 | US6319499 Administering amount of antibody or fragment thereof effective to activate endogenous activity of erythropoietin receptor in mammal, wherein antibody or fragment thereof interacts with peptide consisting of specified amino acid sequence |
| 11/20/2001 | US6319498 Amyloidogenic protein, or fragment thereof, modified with cis-decalin group, cholanoyl structure, cholyl group, diethylenetriaminepentaacetyl group, menthoxyacetyl group, fluorescein-containing group, or n-acetylneuraminyl group |
| 11/20/2001 | US6319496 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof |
| 11/20/2001 | US6319495 Method for restoring glucose responsiveness to insulin secretion |
| 11/20/2001 | US6319494 Treating mammal with modified t-cells comprising chimeric dna encoding membrane bound protein comprising single chain antibody domain that binds to viral or tumor antigen, transmembrane domain, cytoplasmic signal-transducing domain |
| 11/20/2001 | US6319493 Treatment of neoplastic disease with interleukin-10 |
| 11/20/2001 | US6319492 Copolymers of tyrosine-based polyarylates and poly(alkylene oxides) |
| 11/20/2001 | US6319468 Affinity binding-based system for detecting particulates in a fluid |
| 11/20/2001 | CA2224086C Conformationally-restricted combinatorial library composition and method |
| 11/20/2001 | CA2163015C 5' nucleases derived from thermostable dna polymerase |
| 11/20/2001 | CA2156390C Technetium-99m labeled peptides for diagnostic imaging |
| 11/20/2001 | CA2142557C Cytotoxic factor linked with multiple sclerosis and detection and quantitation thereof |
| 11/20/2001 | CA2096418C Expression of pace in host cells and methods of use thereof |
| 11/20/2001 | CA2089753C Interleukin-2-leukotoxin gene fusions and uses therefor |
| 11/20/2001 | CA2084521C Hepatitis c virus antigen polypeptide, production method therefor, and antibody detection method |
| 11/20/2001 | CA2077691C Oxidation resistant thrombomodulin analogs |
| 11/20/2001 | CA2065022C Rubella peptides |
| 11/20/2001 | CA2053864C Modified forms of reproductive hormones |
| 11/20/2001 | CA2033254C Reagent and method for determining activity of retroviral protease |
| 11/20/2001 | CA2008116C Glycine derivatives |
| 11/20/2001 | CA1341320C Insulinotropic hormone |
| 11/19/2001 | CA2325089A1 A novel gene involved in brassinosteroid responses |
| 11/19/2001 | CA2324167A1 A membrane-bound netrin |
| 11/15/2001 | WO2001086307A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers |
| 11/15/2001 | WO2001086293A2 A method for designing and screening random libraries of compounds |
| 11/15/2001 | WO2001086003A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung |
| 11/15/2001 | WO2001085998A1 Haplotypes of the crybb1 gene |
| 11/15/2001 | WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses |
| 11/15/2001 | WO2001085980A2 Enzymatic assays for screening anti-cancer agents |
| 11/15/2001 | WO2001085972A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 11/15/2001 | WO2001085967A2 Corynebacterium glutamicum strain with enhanced secretion activity |
| 11/15/2001 | WO2001085964A2 Over expression of the whn protein |
| 11/15/2001 | WO2001085957A1 Novel polypeptide--- the amyloid precursor protein---binding protein and polynucleotide encoding it |
| 11/15/2001 | WO2001085950A2 Genes of the 1-desoxy-d-xylulose biosynthesis path |
| 11/15/2001 | WO2001085949A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 11/15/2001 | WO2001085948A2 Nucleotide sequences which code for the coryneform acyl carrier protein gene |
| 11/15/2001 | WO2001085947A2 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 11/15/2001 | WO2001085946A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
| 11/15/2001 | WO2001085945A1 Method of inhibiting the formation of by-product in the production of genetically modified polypeptide |
| 11/15/2001 | WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 11/15/2001 | WO2001085943A1 Anergy associated genes |
| 11/15/2001 | WO2001085942A2 Cytoskeleton-associated proteins |
| 11/15/2001 | WO2001085941A2 Myc targets |
| 11/15/2001 | WO2001085940A2 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS |
| 11/15/2001 | WO2001085939A1 Transgenic animal model by mineralocorticoid receptor antisense expression |
| 11/15/2001 | WO2001085938A1 Modified es cells and es cell-specific gene |
| 11/15/2001 | WO2001085937A2 Regulator of g protein signalling (rgs8) |
| 11/15/2001 | WO2001085936A1 F-box containing protein |
| 11/15/2001 | WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 11/15/2001 | WO2001085934A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
| 11/15/2001 | WO2001085933A2 Plakoglobin interacting proteins |
| 11/15/2001 | WO2001085932A2 Immunogenic polypeptides encoded by mage minigenes and uses thereof |
| 11/15/2001 | WO2001085931A2 Polypeptide inhibiting a proton-gated na+ channel |
| 11/15/2001 | WO2001085930A2 Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| 11/15/2001 | WO2001085927A1 Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum |
| 11/15/2001 | WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 11/15/2001 | WO2001085924A2 MODULATION OF η-SECRETASE ACTIVITY |
| 11/15/2001 | WO2001085918A1 Haplotypes of the icam2 gene |
| 11/15/2001 | WO2001085912A2 Presenilin enhancers |
| 11/15/2001 | WO2001085911A2 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 11/15/2001 | WO2001085908A2 Clasp-1 transmembrane protein |
| 11/15/2001 | WO2001085906A2 Catalytically active peptides |
| 11/15/2001 | WO2001085905A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 11/15/2001 | WO2001085904A2 A novel polypeptide--- a human protein 9 containing the fragment of prion characteristic sequence and polynucleotide encoding it |
| 11/15/2001 | WO2001085903A2 A novel polypeptide- human protein 9 which contains a p5cr characteristic sequence fragment and a polynucleotide encoding the same |
| 11/15/2001 | WO2001085798A2 Human monoclonal antibodies to dendritic cells |
| 11/15/2001 | WO2001085794A1 Method of preparation for recombinant guamerin and pharmaceutical compositions containing the recombinant guamerin for wound healing |
| 11/15/2001 | WO2001085793A2 G protein-coupled receptors |
| 11/15/2001 | WO2001085792A2 Mu-1, member of the cytokine receptor family |
| 11/15/2001 | WO2001085791A1 Nucleic acid sequences for novel gpcrs |
| 11/15/2001 | WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 11/15/2001 | WO2001085789A2 Extracellular domain of ryk protein for regulating angiogenesis |
| 11/15/2001 | WO2001085788A2 Human ion channels |
| 11/15/2001 | WO2001085786A2 Human histamine h4 receptor |
| 11/15/2001 | WO2001085785A2 Ph domain-interacting protein |
| 11/15/2001 | WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 11/15/2001 | WO2001085783A2 Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof |
| 11/15/2001 | WO2001085782A2 Fusion receptor from tnf family |
| 11/15/2001 | WO2001085781A2 Repair of nerve damage |